These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
291 related articles for article (PubMed ID: 11519827)
41. Vascular endothelial growth factor content in metastasizing and nonmetastasizing Dunning prostatic adenocarcinoma. Häggström S; Bergh A; Damber JE Prostate; 2000 Sep; 45(1):42-50. PubMed ID: 10960841 [TBL] [Abstract][Full Text] [Related]
42. A radicicol derivative, KF58333, inhibits expression of hypoxia-inducible factor-1alpha and vascular endothelial growth factor, angiogenesis and growth of human breast cancer xenografts. Kurebayashi J; Otsuki T; Kurosumi M; Soga S; Akinaga S; Sonoo H Jpn J Cancer Res; 2001 Dec; 92(12):1342-51. PubMed ID: 11749701 [TBL] [Abstract][Full Text] [Related]
43. Androgen deprivation induces selective outgrowth of aggressive hormone-refractory prostate cancer clones expressing distinct cellular and molecular properties not present in parental androgen-dependent cancer cells. Tso CL; McBride WH; Sun J; Patel B; Tsui KH; Paik SH; Gitlitz B; Caliliw R; van Ophoven A; Wu L; deKernion J; Belldegrun A Cancer J; 2000; 6(4):220-33. PubMed ID: 11038142 [TBL] [Abstract][Full Text] [Related]
44. Up-regulation of vascular endothelial growth factor/vascular permeability factor in mouse skin carcinogenesis correlates with malignant progression state and activated H-ras expression levels. Larcher F; Robles AI; Duran H; Murillas R; Quintanilla M; Cano A; Conti CJ; Jorcano JL Cancer Res; 1996 Dec; 56(23):5391-6. PubMed ID: 8968091 [TBL] [Abstract][Full Text] [Related]
45. Upregulation of vascular endothelial growth factor by cobalt chloride-simulated hypoxia is mediated by persistent induction of cyclooxygenase-2 in a metastatic human prostate cancer cell line. Liu XH; Kirschenbaum A; Yao S; Stearns ME; Holland JF; Claffey K; Levine AC Clin Exp Metastasis; 1999; 17(8):687-94. PubMed ID: 10919714 [TBL] [Abstract][Full Text] [Related]
46. Severe combined immunodeficient-hu model of human prostate cancer metastasis to human bone. Nemeth JA; Harb JF; Barroso U; He Z; Grignon DJ; Cher ML Cancer Res; 1999 Apr; 59(8):1987-93. PubMed ID: 10213511 [TBL] [Abstract][Full Text] [Related]
47. Vascular endothelial growth factor overproduced by tumour cells acts predominantly as a potent angiogenic factor contributing to malignant progression. Aonuma M; Saeki Y; Akimoto T; Nakayama Y; Hattori C; Yoshitake Y; Nishikawa K; Shibuya M; Tanaka NG Int J Exp Pathol; 1999 Oct; 80(5):271-81. PubMed ID: 10607018 [TBL] [Abstract][Full Text] [Related]
48. Highly tumorigenic human androgen receptor-positive prostate cancer cells overexpress angiogenin. Kawada M; Inoue H; Arakawa M; Takamoto K; Masuda T; Ikeda D Cancer Sci; 2007 Mar; 98(3):350-6. PubMed ID: 17270024 [TBL] [Abstract][Full Text] [Related]
49. [Inhibition of growth and metastasis of human giant cell carcinoma of the lung by transfection of antisense VEGF121 cDNA]. Wu X; Zheng J; Fu J; You J; Cui X; Wang J; Fang W; Zhou A; Wu B Zhonghua Bing Li Xue Za Zhi; 2000 Oct; 29(5):363-6. PubMed ID: 11866937 [TBL] [Abstract][Full Text] [Related]
50. Tumor-induced activation of lymphatic endothelial cells via vascular endothelial growth factor receptor-2 is critical for prostate cancer lymphatic metastasis. Zeng Y; Opeskin K; Goad J; Williams ED Cancer Res; 2006 Oct; 66(19):9566-75. PubMed ID: 17018613 [TBL] [Abstract][Full Text] [Related]
51. In vitro and in vivo angiogenesis in PC12 pheochromocytoma cells is mediated by vascular endothelial growth factor. Middeke M; Hoffmann S; Hassan I; Wunderlich A; Hofbauer LC; Zielke A Exp Clin Endocrinol Diabetes; 2002 Nov; 110(8):386-92. PubMed ID: 12518248 [TBL] [Abstract][Full Text] [Related]
52. A potential autocrine role for vascular endothelial growth factor in prostate cancer. Jackson MW; Roberts JS; Heckford SE; Ricciardelli C; Stahl J; Choong C; Horsfall DJ; Tilley WD Cancer Res; 2002 Feb; 62(3):854-9. PubMed ID: 11830543 [TBL] [Abstract][Full Text] [Related]
53. Antitumor effect of reduction of 150-kDa oxygen-regulated protein expression on human prostate cancer cells. Miyagi T; Hori O; Koshida K; Egawa M; Kato H; Kitagawa Y; Ozawa K; Ogawa S; Namiki M Int J Urol; 2002 Oct; 9(10):577-85. PubMed ID: 12445237 [TBL] [Abstract][Full Text] [Related]
54. Tumor-derived vascular endothelial growth factor up-regulates angiopoietin-2 in host endothelium and destabilizes host vasculature, supporting angiogenesis in ovarian cancer. Zhang L; Yang N; Park JW; Katsaros D; Fracchioli S; Cao G; O'Brien-Jenkins A; Randall TC; Rubin SC; Coukos G Cancer Res; 2003 Jun; 63(12):3403-12. PubMed ID: 12810677 [TBL] [Abstract][Full Text] [Related]
55. Acquired resistance to the antitumor effect of epidermal growth factor receptor-blocking antibodies in vivo: a role for altered tumor angiogenesis. Viloria-Petit A; Crombet T; Jothy S; Hicklin D; Bohlen P; Schlaeppi JM; Rak J; Kerbel RS Cancer Res; 2001 Jul; 61(13):5090-101. PubMed ID: 11431346 [TBL] [Abstract][Full Text] [Related]
56. Role of high expression levels of CXCR4 in tumor growth, vascularization, and metastasis. Darash-Yahana M; Pikarsky E; Abramovitch R; Zeira E; Pal B; Karplus R; Beider K; Avniel S; Kasem S; Galun E; Peled A FASEB J; 2004 Aug; 18(11):1240-2. PubMed ID: 15180966 [TBL] [Abstract][Full Text] [Related]
57. Role of host microenvironment in angiogenesis and microvascular functions in human breast cancer xenografts: mammary fat pad versus cranial tumors. Monsky WL; Mouta Carreira C; Tsuzuki Y; Gohongi T; Fukumura D; Jain RK Clin Cancer Res; 2002 Apr; 8(4):1008-13. PubMed ID: 11948107 [TBL] [Abstract][Full Text] [Related]
58. The 121 amino acid isoform of vascular endothelial growth factor is more strongly tumorigenic than other splice variants in vivo. Zhang HT; Scott PA; Morbidelli L; Peak S; Moore J; Turley H; Harris AL; Ziche M; Bicknell R Br J Cancer; 2000 Jul; 83(1):63-8. PubMed ID: 10883669 [TBL] [Abstract][Full Text] [Related]
59. Hypoxia-induced metastasis of human melanoma cells: involvement of vascular endothelial growth factor-mediated angiogenesis. Rofstad EK; Danielsen T Br J Cancer; 1999 Aug; 80(11):1697-707. PubMed ID: 10468285 [TBL] [Abstract][Full Text] [Related]
60. Sex hormone-induced prostatic carcinogenesis in the noble rat: the role of insulin-like growth factor-I (IGF-I) and vascular endothelial growth factor (VEGF) in the development of prostate cancer. Wang YZ; Wong YC Prostate; 1998 May; 35(3):165-77. PubMed ID: 9582085 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]